Aurum Biosciences Ltd is a UK based clinical stage biopharmaceutical company developing novel oxygen carriers for use as therapeutics and diagnostics, initially for Acute Ischaemic Stroke (AIS) and Inflammation Imaging. Follow-on indications include heart disease, cardiac arrest, oncology, spinal cord injury (SCI), and traumatic brain injury (TBI).